A point mutation in the last intron responsible for increased expression and transforming activity of the c-Ha-ras oncogene

[1]  J. Sambrook,et al.  Molecular Cloning: A Laboratory Manual , 2001 .

[2]  S. Rosenberg,et al.  Important advances in oncology 1986 , 1994 .

[3]  A. Levinson,et al.  High-level expression of c-H-ras1 fails to fully transform rat-1 cells , 1988, Molecular and cellular biology.

[4]  R. Gelinas,et al.  A fetal globin gene mutation in A gamma nondeletion hereditary persistence of fetal hemoglobin increases promoter strength in a nonerythroid cell , 1988, Molecular and cellular biology.

[5]  C. Marshall,et al.  Activated N-ras controls the transformed phenotype of HT1080 human fibrosarcoma cells , 1987, Cell.

[6]  M. Groudine,et al.  Mutations in the first exon are associated with altered transcription of c-myc in Burkitt lymphoma. , 1987, Science.

[7]  Y. Kan,et al.  Detection of sickle cell anaemia and thalassaemias , 1987, Nature.

[8]  S. Weissman,et al.  Expression of the affected A gamma globin gene associated with Greek nondeletion hereditary persistence of fetal hemoglobin , 1987, Molecular and cellular biology.

[9]  D. Spandidos,et al.  Transcriptional enhancer activity in the variable tandem repeat DNA sequence downstream of the human Ha‐ras1 gene , 1987, FEBS letters.

[10]  E. Racker,et al.  Opposing effects of a ras oncogene on growth factor-stimulated phosphoinositide hydrolysis: desensitization to platelet-derived growth factor and enhanced sensitivity to bradykinin. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[11]  B. Wasylyk,et al.  The c-Ha-ras oncogene and a tumor promoter activate the polyoma virus enhancer , 1987, Cell.

[12]  D. Moore,et al.  Human growth hormone as a reporter gene in regulation studies employing transient gene expression , 1986, Molecular and cellular biology.

[13]  D. Goeddel,et al.  Expression in rat fibroblasts of a human transforming growth factor-α cDNA results in transformation , 1986, Cell.

[14]  R. Weinberg,et al.  Behavior of myc and ras oncogenes in transformation of rat embryo fibroblasts , 1986, Molecular and cellular biology.

[15]  P. Chambon,et al.  A mutated polyoma virus enhancer which is active in undifferentiated embryonal carcinoma cells is not repressed by adenovirus-2 E1A products , 1986, Nature.

[16]  R. Myers,et al.  Fine structure genetic analysis of a beta-globin promoter. , 1986, Science.

[17]  B. Franza,et al.  In vitro establishment is not a sufficient prerequisite for transformation by activated ras oncogenes , 1986, Cell.

[18]  I. Pastan,et al.  Promoter region of the human Harvey ras proto-oncogene: similarity to the EGF receptor proto-oncogene promoter. , 1985, Science.

[19]  K. Mullis,et al.  Enzymatic amplification of beta-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia. , 1985, Science.

[20]  M. Barbacid,et al.  ras gene Amplification and malignant transformation , 1985, Molecular and cellular biology.

[21]  L. Kedes,et al.  Evolution of the functional human beta-actin gene and its multi-pseudogene family: conservation of noncoding regions and chromosomal dispersion of pseudogenes , 1985, Molecular and cellular biology.

[22]  P. Rigby,et al.  Negative regulation of viral enhancers in undifferentiated embryonic stem cells , 1985, Cell.

[23]  B. Stillman,et al.  Replication and supercoiling of simian virus 40 DNA in cell extracts from human cells , 1985, Molecular and cellular biology.

[24]  Michael Boshart,et al.  A very strong enhancer is located upstream of an immediate early gene of human cytomegalovirus , 1985, Cell.

[25]  R. Kaufman.  Identification of the components necessary for adenovirus translational control and their utilization in cDNA expression vectors. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[26]  P. Seeburg,et al.  Biological properties of human c-Ha-ras1 genes mutated at codon 12 , 1984, Nature.

[27]  M. Kraus,et al.  A position 12-activated H-ras oncogene in all HS578T mammary carcinosarcoma cells but not normal mammary cells of the same patient. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[28]  D. Goeddel,et al.  Comparative biochemical properties of normal and activated human ras p21 protein , 1984, Nature.

[29]  D. Spandidos,et al.  Malignant transformation of early passage rodent cells by a single mutated human oncogene , 1984, Nature.

[30]  H. Ruley.  Adenovirus early region 1A enables viral and cellular transforming genes to transform primary cells in culture , 1983, Nature.

[31]  R. Newbold,et al.  Fibroblast immortality is a prerequisite for transformation by EJ c-Ha-ras oncogene , 1983, Nature.

[32]  Robert A. Weinberg,et al.  Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes , 1983, Nature.

[33]  E. Reddy,et al.  Nucleotide sequence analysis of the T24 human bladder carcinoma oncogene. , 1983, Science.

[34]  E. Chen,et al.  Complete nucleotide sequences of the T24 human bladder carcinoma oncogene and its normal homologue , 1983, Nature.

[35]  A. Levinson,et al.  Plasmid-directed synthesis of hepatitis B surface antigen in monkey cells , 1983, Molecular and cellular biology.

[36]  Kenji Shimizu,et al.  Activation of the T24 bladder carcinoma transforming gene is linked to a single amino acid change , 1982, Nature.

[37]  Eugenio Santos,et al.  A point mutation is responsible for the acquisition of transforming properties by the T24 human bladder carcinoma oncogene , 1982, Nature.

[38]  Cori Bargmann,et al.  Mechanism of activation of a human oncogene , 1982, Nature.

[39]  S. McKnight,et al.  Transcriptional control signals of a eukaryotic protein-coding gene. , 1982, Science.

[40]  D. Lowy,et al.  Tumorigenic transformation of mammalian cells induced by a normal human gene homologous to the oncogene of Harvey murine sarcoma virus , 1982, Nature.

[41]  Stephen M. Mount,et al.  A catalogue of splice junction sequences. , 1982, Nucleic acids research.

[42]  D. Moore,et al.  Human growth hormone DNA sequence and mRNA structure: possible alternative splicing. , 1981, Nucleic acids research.

[43]  E. L. Springer,et al.  Two syngeneic cell lines from human breast tissue: the aneuploid mammary epithelial (Hs578T) and the diploid myoepithelial (Hs578Bst) cell lines. , 1977, Journal of the National Cancer Institute.

[44]  A. van der Eb,et al.  A new technique for the assay of infectivity of human adenovirus 5 DNA. , 1973, Virology.

[45]  Henry A. Erlich,et al.  Characterization of β-thalassaemia mutations using direct genomic sequencing of amplified single copy DNA , 1987, Nature.

[46]  M. Aebi,et al.  Precision and orderliness in splicing , 1987 .

[47]  A. Godwin,et al.  Regulation of a metallothionein-rasT24 fusion gene by zinc results in graded alterations in cell morphology and growth. , 1987, Oncogene.

[48]  A. Levinson,et al.  A repetitive sequence element 3′ of the human c‐Ha‐ras1 gene has enhancer activity , 1987, Journal of cellular physiology. Supplement.

[49]  C. Benjamin,et al.  Loss of platelet-derived growth factor-stimulated phospholipase activity in NIH-3T3 cells expressing the EJ-ras oncogene. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[50]  J. Rhim,et al.  Ha-ras oncogenes are activated by somatic alterations in human urinary tract tumours , 1984, Nature.

[51]  H. Varmus.  The molecular genetics of cellular oncogenes. , 1984, Annual review of genetics.